Cell therapy
Microbiome may influence the health of some people diagnosed with autism
A collaborative study involving Israel, the US, Europe, Ecuador, Russia, and China reveals promising insights into the gut-brain axis in autism spectrum disorder.
Immunai, BCM developing first-in-human cell therapy for neuroblastoma
New research uncovers method to prevent DNA breakdown, aging - study
'Sneaky' cancer tumors create shelters to hide from immunotherapy - study
First time in Israel: Adult stem cells transplanted in toddler with rare skin disease
The first transplantation of the mesenchymal stem cells (MSC) was given as part of compassionate treatment to a two-and-a-half-year-old boy suffering from epidermolysis bullosa (EB).
AI system developed to determine optimal conditions for regenerative medicine
A robotic AI system has been developed by scientists that is capable of improving stem cell culture procedures that are utilized in regenerative medicine.
Cell therapy co. Gamida Cell announces USD 75 m. financing
Gamida Cell is a cell therapy company working to develop and commercialize cures for blood cancers and blood diseases.
Pluristem to terminate Phase III study of critical limb ischemia (CLI)
While the CLI study was unsuccessful, Yanay said the company is maintaining a forward-thinking attitude, looking toward the development of other treatments it has in the works.
Investigational drug proven to prolong survival of ALS patients - study
The median overall survival for all CENTAUR study participants being administered AMX0035 was 6.5 months longer than the group originally randomized to placebo.
Israel’s Immunai first to map whole immune system, scores $20m. investment
Immunai says it has mapped out millions of immune cells and their functions that could help detect, diagnose and treat cancer and many other diseases.
Israeli cell therapy company offers solution after failed Russian experiment
Radiation poisoning, known in the medical world as acute radiation syndrome or ARS, is a grave illness that often leads to death.
Pluristem gets positive results from radiation treatment trials
“We believe that this outcome is an important contribution to protect the armed and medical forces which may need to enter contaminated areas,” Chief Executive Officer Yaky Yanay said.
BGU researchers discover sense of ‘touch’ in blood cells
Lymphocytes found to differentiate healthy cells from sick ones through chemical and mechanical reactions
USFDA clears Plursitem for expanded access program
Patients suffering from critical limb ischemia can now benefit without being part of clinical trials